VIA Pharmaceuticals Inc
OTC:VIAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VIA Pharmaceuticals Inc
OTC:VIAP
|
US |
|
Y
|
YouGov PLC
SWB:Y1G
|
UK |
|
Wellnex Life Ltd
F:22W0
|
AU |
|
Y
|
Yamada Green Resources Ltd
SGX:BJV
|
CN |
|
E
|
Exyn Technologies Inc
NASDAQ:EXYN
|
US |
|
L
|
Lincoln Minerals Ltd
ASX:LMLND
|
AU |
|
B
|
Bouygues SA
XMUN:BYG
|
FR |
|
Noble Iron Inc
XTSX:NIR
|
CA |
|
M
|
Maritime Launch Services Ltd
OTC:MAXQF
|
CA |
|
T
|
Tlou Energy Ltd
LSE:TLOU
|
AU |
|
Pax Global Technology Ltd
HKEX:327
|
HK |
|
I
|
I Yuan Precision Industrial Co Ltd
TPEX:2235
|
TW |
|
J
|
Jenkongklai PCL
SET:JPARK
|
TH |
|
H
|
Hong Leong Capital Bhd
KLSE:HLCAP
|
MY |
|
E
|
Eyez Inc
TSE:5242
|
JP |
|
F
|
Fancamp Exploration Ltd
XTSX:FNC
|
CA |
|
360 Capital REIT
ASX:TOT
|
AU |
|
M
|
Marga Abhinaya Abadi Tbk PT
IDX:MABA
|
ID |
|
S
|
Sona Nanotech Inc
CNSX:SONA
|
CA |
|
Dormakaba Holding AG
OTC:DRRKD
|
CH |
Bankruptcy Probability
VIA Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
VIA Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
V
|
VIA Pharmaceuticals Inc
OTC:VIAP
|
20.6 USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
232.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
VIA Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, VIA Pharmaceuticals Inc has total debt of 14m USD. This includes both short-term (14m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
